Aspire Biopharma Holdings's total assets for Q2 2025 were $989.42K, a decrease of -49.66% from the previous quarter. ASBP total liabilities were $10.61M for the fiscal quarter, a 18.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.